Alemtuzumab in Myelodysplastic Syndrome (MDS), Aplastic Anemia, and T-Cell Large Granular Lymphocytic Leukemia (T-GL)
Status:
Terminated
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to determine the effectiveness of alemtuzumab in
patients with aplastic anemia, MDS, or T-Cell large granular lymphocytic leukemia. The safety
of alemtuzumab will also be studied.